Search

Your search keyword '"Westervelt, Peter"' showing total 1,296 results

Search Constraints

Start Over You searched for: Author "Westervelt, Peter" Remove constraint Author: "Westervelt, Peter"
1,296 results on '"Westervelt, Peter"'

Search Results

151. 475 - Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

152. 386 - A Single-Arm, Open-Label, Pilot Study of the JAK1 Selective Inhibitor Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome in T-Cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation

153. 43 - Mutation Analysis in Patients with High-Risk Myelodysplastic Syndrome Receiving Allogeneic Hematopoietic Cell Transplantation Based on Biological Donor Availability: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Study 1102

155. Recognizing and managing the expanded risk of tumor lysis syndrome in hematologic and solid malignancies

157. Erratum: The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma (Cell Reports (2018) 23(1) (313–326.e5) (S2211124718304364) (10.1016/j.celrep.2018.03.075))

158. The Immune Landscape of Cancer

160. A randomized phase II trial of CX-01 with standard therapy in elderly patients with acute myeloid leukemia (AML).

164. Immune Escape of Relapsed AML Cells after Allogeneic Transplantation

165. Phase 1 First-in-Human Trial of AMV564, a Bivalent Bispecific (2x2) CD33/CD3 T-Cell Engager, in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)

166. Improving Risk Assessment of AML with a Precision Genomic Strategy to Assess Mutation Clearance

168. Phase II Study Evaluating the Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem and Progenitor Cells for Allogeneic Hematopoietic Cell Transplantation and Phenotypic Characterization of the Leukapheresis Product

169. Exome analysis of treatment‐related AML after APL suggests secondary evolution

170. Effect of Antihuman T Lymphocyte Globulin on Immune Recovery after Myeloablative Allogeneic Stem Cell Transplantation with Matched Unrelated Donors: Analysis of Immune Reconstitution in a Double-Blind Randomized Controlled Trial

172. Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

173. A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily

174. Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy

177. Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML

178. 3 - A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplantation to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Advanced Myelodysplastic Syndrome: Blood and Marrow Transplant Clinical Trials Network Study 1102

183. Rapid expansion of preexisting nonleukemic hematopoietic clones frequently follows induction therapy for de novo AML

184. Mutation Clearance after Transplantation for Myelodysplastic Syndrome

186. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients

187. A Phase 1 Trial of CNDO-109–Activated Natural Killer Cells in Patients with High-Risk Acute Myeloid Leukemia

188. Comprehensive Characterization of Cancer Driver Genes and Mutations

189. Abstract 5704: Mass cytometry identifies the expansion, persistence, and immune checkpoints of adoptively transferred memory-like NK cells in patients with leukemia

190. First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

191. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

193. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

194. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

195. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

196. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

197. Oncogenic Signaling Pathways in The Cancer Genome Atlas

198. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation

199. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

200. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer

Catalog

Books, media, physical & digital resources